Life-Sciences-USA.com
The Transatlantic Life Sciences Web Portal

This is a free web portal for the life sciences in North America, Europe and Israel... » read more

Merck to Acquire Themis Bioscience for Undisclosed Sum (2020-05-26)
Merck to Apply its Industry-Leading Vaccine Development Capabilities to SARS-CoV-2 Vaccine Program Originated by Themis and Institut Pasteur Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Themis, a company focused on vaccines and imm...
Roche Acquires Stratos Genomics for Undisclosed Sum (2020-05-22)
> Genomics insights generated through sequencing an individual's DNA play a critical role in personalised healthcare and clinical diagnostics of the future > Roche is committed to developing a nanopore sequencer with the aim of providing the healthcare community...
HotSpot Therapeutics Completes $65m Series B Round (2020-05-21)
Financing Accelerates Development of First-in-Class Therapies with Genetically Validated Mechanisms for Treatment of Autoimmune Diseases, Rare Diseases and Cancer HotSpot Therapeutics, Inc, a biotechnology company pioneering the discovery and development of fi...
Nautilus Biotechnology Raises $76m in Series B Funding (2020-05-21)
Vulcan Capital-led investment will enable Nautilus to bring a next-generation, single-molecule proteomics platform to market. Nautilus Biotechnology, a company pioneering a high-throughput, low-cost platform for analyzing and quantifying the human proteome, to...
Octant: $30m Series A Round Led by Andreessen Horowitz (2020-05-20)
Company also Applying its High-throughput RNA-amplicon Sequencing Platform to Accelerate COVID-19 Testing Efforts Octant, Inc., a synthetic biology drug discovery company designing small molecule, multi-target drug leads for multifactorial diseases announced t...
Phlow Awarded $354m to Manufacture Essential Medicines in US (2020-05-19)
Move Strengthens America's Supply Chain and Supports COVID-19 Response Phlow, a U.S.-based, public benefit drug manufacturing corporation, has received federal government funding of $354 million for advanced manufacturing of America's most essential medicines ...
Singapore-based Holmusk Closes $21.5m Series A Round (2020-05-18)
Holmusk, a leading data science and health technology company, today announced a US$21.5 million funding round. The round was led by Optum Ventures (OV) and Health Catalyst Capital (HCC) and included existing investors Heritas Capital and other individuals. Holm...
Moderna Prices up to $1.54b Public Offering of Common Stock (2020-05-18)
Moderna, Inc. (Nasdaq: MRNA), a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced the pricing of an underwritten public offering of 17,...
Calliditas Files for US IPO at Nasdaq Global Market (2020-05-14)
Calliditas Therapeutics AB (publ) (“Calliditas” or the “Company”) has today publicly filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission (“SEC”) relating to a proposed initial public offering of its American Depositary Shares...
Immunai Emerges from Stealth with $20m Seed Funding (2020-05-14)
Ex-Palantir engineers and MIT, Harvard & Stanford researchers raise $20M in seed funding to better detect, diagnose and treat disease by mapping out immune cells and their functions with machine learning Today, Immunai launches out of stealth to map the entire...

Life-Sciences-USA.com is your doorway to the Transatlantic life sciences!

[LSUS] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the North America, Europe and Israel.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSUS] is 100% Made in Germany!

» Start here with the latest News!

Picture [MSC] Mass-Spec-Capital.com – The Mass Spectrometry Web Portal 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]